PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

IDX:DGNS Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,382	4,209	10,245	28,011	44,720	16,538
Short-Term Investments	959.59	959.59	1,696	2,543	6,507	-
Cash & Short-Term Investments	6,341	5,169	11,941	30,553	51,227	16,538
Cash Growth	-23.73%	-56.71%	-60.92%	-40.36%	209.75%	1086.91%
Accounts Receivable	43,314	41,810	38,280	42,422	41,730	50,816
Other Receivables	7,426	7,079	6,972	7,033	32,209	5,977
Receivables	50,741	48,889	45,252	49,455	73,939	81,273
Inventory	5,085	5,043	5,142	6,567	7,760	5,813
Prepaid Expenses	177.05	275.79	194.89	266.08	784.92	56.19
Other Current Assets	22,696	19,231	25,275	31,532	20,153	1,473
Total Current Assets	85,040	78,608	87,805	118,373	153,864	105,154
Property, Plant & Equipment	201,762	202,426	164,248	109,219	87,107	20,108
Long-Term Investments	12,951	12,951	12,951	8,445	-	-
Other Intangible Assets	1,479	1,353	720.43	681.12	-	-
Long-Term Deferred Tax Assets	815.57	815.57	1,031	1,020	1,012	762.7
Long-Term Deferred Charges	-	-	-	-	-	6,550
Other Long-Term Assets	2,736	3,869	4,719	2,198	-	-
Total Assets	304,782	300,022	271,475	239,936	241,983	132,575
Accounts Payable	8,785	9,551	6,090	3,078	4,524	15,825
Accrued Expenses	3,652	4,116	3,178	1,556	3,125	140.09
Current Portion of Long-Term Debt	3,057	152.08	-	1,701	-	-
Current Portion of Leases	4,385	5,012	3,710	1,811	2,390	634.66
Current Income Taxes Payable	757.22	255.12	268.87	674.83	16,013	12,763
Current Unearned Revenue	2,039	1,748	651.53	893.77	-	-
Other Current Liabilities	365.2	772.59	545.72	777.24	576.26	1,249
Total Current Liabilities	23,042	21,606	14,444	10,492	26,628	30,612
Long-Term Debt	49,817	44,817	30,000	9,358	-	677.76
Long-Term Leases	20,526	20,401	21,004	409.04	2,888	1,273
Long-Term Unearned Revenue	7,565	7,820	-	-	-	-
Other Long-Term Liabilities	8,043	7,954	8,280	7,563	7,563	237.09
Total Liabilities	110,375	103,890	75,885	29,508	40,182	33,508
Common Stock	31,250	31,250	31,250	31,250	31,250	25,000
Additional Paid-In Capital	36,707	36,707	36,707	36,707	36,707	28.98
Retained Earnings	130,540	132,265	131,518	145,173	132,509	74,205
Comprehensive Income & Other	-4,090	-4,090	-3,884	-2,702	1,335	-167.65
Shareholders' Equity	194,407	196,132	195,590	210,428	201,800	99,066
Total Liabilities & Equity	304,782	300,022	271,475	239,936	241,983	132,575
Total Debt	77,786	70,382	54,714	13,279	5,277	2,586
Net Cash (Debt)	-71,444	-65,213	-42,773	17,274	45,950	13,953
Net Cash Growth	-	-	-	-62.41%	229.33%	-
Net Cash Per Share	-57.16	-52.17	-34.22	13.82	37.04	13.95
Filing Date Shares Outstanding	1,250	1,250	1,250	1,250	1,250	1,000
Total Common Shares Outstanding	1,250	1,250	1,250	1,250	1,250	1,000
Working Capital	61,998	57,002	73,361	107,881	127,236	74,542
Book Value Per Share	155.53	156.91	156.47	168.34	161.44	99.07
Tangible Book Value	192,928	194,779	194,870	209,747	201,800	99,066
Tangible Book Value Per Share	154.34	155.82	155.90	167.80	161.44	99.07
Land	54,643	54,643	43,655	43,655	43,655	-
Machinery	47,126	46,447	44,285	39,548	31,771	18,263
Construction In Progress	89,324	88,001	53,061	18,411	311.4	-
Leasehold Improvements	27,721	27,857	26,026	23,672	14,201	1,580

Source: S&P Global Market Intelligence. Standard template. Financial Sources.